Submission of certificate under Reg. 74(5) of SEBI (DP) for 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kobo Biotech Ltd has submitted a certificate to BSE from its Registrar and Share Transfer Agent, XL Softech Systems Ltd, under SEBI Regulation 74(5) for the quarter ended 31 March 2025. The certificate confirms that securities received from depository participants for dematerialization during the quarter were properly processed, and physical certificates were mutilated and cancelled within the required 30-day timeline. The depository names were duly substituted as registered owners in the company's register of members. A notable point is that the letter has been signed by an Insolvency Professional, Namrata Randeri, and the correspondence email is 'cirp.kobobiotech@gmail.com', indicating the company continues to be under Corporate Insolvency Resolution Process (CIRP).
This is a routine quarterly compliance filing related to share dematerialization processing and does not signal any new corporate action or material change for shareholders. However, the signatory being an Insolvency Professional confirms that the CIRP status of the company remains ongoing, which remains the key concern for equity holders.